A Crossover Study of DWJ1525 to Evaluate the Safety and Pharmacokinetic Properties in Healthy Volunteers
Clinical trial NCT05192395 · COMPLETED
Trial details
- NCT number
- NCT05192395
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-15
- Primary completion
- 2022-05-24
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.